Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: J Pain Symptom Manage. 2020 Oct 20;61(6):1188–1195.e2. doi: 10.1016/j.jpainsymman.2020.10.017

Table 3.

Demographic and Clinical Characteristics by Group (N = 477)a

Latent Group
High Prevalence (N = 108, 22.6%)
Moderate Prevalence (N = 245, 51.4%)
Low Prevalence (N = 124, 26.0%)
Variable Mean (SD) Mean (SD) Mean (SD)

Age 13.52 (3.4) 13.52 (3.4) 13.31 (3.5)
χ2 = 0.341, P = 0.843
Hemoglobin 10.35 (1.4) 10.67 (1.7) 10.64 (1.5)
χ2 = 3.131, P = 0.209
Gender, N (%)
 Female 68 (63.0) 104 (42.5) 52 (41.9)
 Male 40 (37.0) 141 (57.6) 72 (58.1)
χ2 = 14.36, P = 0.001
Parent education, N (%)
 < College 18 (17.0) 49 (20.4) 35 (28.7)
 College/university 69 (65.1) 155 (64.6) 70 (57.4)
 Postgraduate 19 (17.9) 36 (15.0) 17 (13.9)
χ2 = 5.41, P = 0.247
Race/ethnicity, N (%)
 White 60 (55.6) 136 (55.5) 72 (58.1)
 Black 17 (15.7) 33 (13.5) 27 (21.8)
 Hispanic 19 (17.6) 35 (14.3) 11 (8.9)
 Others 12 (11.1) 41 (16.7) 14 (11.3)
χ2 = 9.61, P = 0.142
Time since diagnosis, N (%)
 ≤Median (0.30) 72 (66.7) 137 (55.9) 65 (52.4)
 >Median (0.30) 36 (33.3) 108 (44.1) 59 (47.6)
χ2 = 5.27, P = 0.071
a

Sample size slightly varies by variables due to missing values.